← All diseases Muscles and connective tissue

Becker muscular dystrophy

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest Level of Evidence Only (35)Meta-analysis (9)Randomized trial (10)Systematic review (9)Phase 3 study (7)Clinical trial (510)Review article (203)Early study (phase 1 or 2) (27)Case description (103)Laboratory or animal study (64)Commentary or editorial (52)Retracted Publication (4) Studies Currently Seeking Participants Only (38)

Filter

Publications (1249)

• Empagliflozin treatment rescues abnormally reduced Na(+) currents in ventricular cardiomyocytes from dystrophin-deficient mdx mice. (2024/02/01) ♡
• Self- and Caregiver-Reported Participation, Quality of Life, and Related Mood and Behavior Challenges in People Living With Dystrophinopathies. (2024/02/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. enOsCas12f1-mediated exon skipping for Duchenne muscular dystrophy therapy in humanized mouse model. (2024/02/01) ♡
• A novel biomarker of fibrofatty replacement in dystrophinopathies identified by integrating transcriptome, magnetic resonance imaging, and pathology data. (2024/02/01) ♡
• Dual task impact on functional mobility and interaction of functional level and balance in patients with Duchenne muscular dystrophy. (2024/02/01) ♡
• Neurodiversity, treatment compliance and survival in adults with Duchenne muscular dystrophy: a single-centre retrospective cohort review. (2024/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A new pseudoexon activation due to ultrarare branch point formation in Duchenne muscular dystrophy. (2024/02/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Bisphosphonates in Glucocorticoid-Treated Patients With Duchenne Muscular Dystrophy: A Systematic Review and Grading of the Evidence. (2024/01/23) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Neuromuscular disorders in the omics era. (2024/01/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. DMD deletions underlining mild dystrophinopathies: literature review highlights phenotype-related mutation clusters and provides insights about genetic mechanisms and prognosis. (2024/01/15) ♡
• Clinical practice guidelines for the diagnosis and management of Duchenne muscular dystrophy: a scoping review. (2024/01/05) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Sustained clinical benefit following systemic gene replacement therapy in Duchenne muscular dystrophy. (2024/01/01) ♡
• Developing a Natural History Model for Duchenne Muscular Dystrophy. (2024/01/01) ♡
• Antioxidant effects of LEDT in dystrophic muscle cells: involvement of PGC-1α and UCP-3 pathways. (2024/01/01) ♡
• Reporting of paediatric osteoporotic vertebral fractures in Duchenne muscular dystrophy and potential impact on clinical management: the need for standardised and structured reporting. (2024/01/01) ♡
• Prevalence of Adeno-Associated Virus-9-Neutralizing Antibody in Chinese Patients with Duchenne Muscular Dystrophy. (2024/01/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Fat embolism syndrome in Duchenne muscular dystrophy: Report on a novel case and systematic literature review. (2024/01/01) ♡
• The Interaction of Duchenne Muscular Dystrophy and Insulin Resistance. (2024/01/01) ♡
• Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study. (2024/01/01) ♡
• Evaluation of pro-regenerative and anti-inflammatory effects of isolecanoric acid in the muscle: Potential treatment of Duchenne Muscular Dystrophy. (2024/01/01) ♡
• Understanding anxiety experienced by young males with Duchenne muscular dystrophy: a qualitative focus group study. (2024/01/01) ♡
• Adults living with Duchenne muscular dystrophy: old and new challenges in a cohort of 19 patients in their third to fifth decade. (2024/01/01) ♡
• [Physical medical rehabilitation of patients with dystrophinopathies: dynamics of the disease's course considering clinical anthropometric indicators]. (2024/01/01) ♡
• Continuity of care with ataluren in Duchenne Muscular Dystrophy patients with nonsense mutations after loss of ambulation. Personal experience. (2023/12/31) ♡
• Discovery of YSR734: A Covalent HDAC Inhibitor with Cellular Activity in Acute Myeloid Leukemia and Duchenne Muscular Dystrophy. (2023/12/28) ♡
• Prenatal Exome Sequencing Analysis in Fetuses with Various Ultrasound Findings. (2023/12/28) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. AMONDYS 45 (Casimersen), a Novel Antisense Phosphorodiamidate Morpholino Oligomer: Clinical Considerations for Treatment in Duchenne Muscular Dystrophy. (2023/12/28) ♡
• Establishment of a Triple Quadrupole HPLC-MS Quantitation Method for Dystrophin Protein in Mouse and Human Skeletal Muscle. (2023/12/25) ♡
• Astaxanthin Ameliorates Worsened Muscle Dysfunction of MDX Mice Fed with a High-Fat Diet through Reducing Lipotoxicity and Regulating Gut Microbiota. (2023/12/21) ♡
• mCherry on Top: A Positive Read-Out Cellular Platform for Screening DMD Exon Skipping Xenopeptide-PMO Conjugates. (2023/12/20) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Efficacy of N-163 beta-glucan in beneficially improving biomarkers of relevance to muscle function in patients with muscular dystrophies in a pilot clinical study. (2023/12/20) ♡
• Estimating health state utilities in Duchenne muscular dystrophy using the health utilities index and EQ-5D-5L. (2023/12/15) ♡
• A qualitative study to understand the Duchenne muscular dystrophy experience from the parent/patient perspective. (2023/12/12) ♡
• Derivation and validation of diagnostic models for myocardial fibrosis in duchenne muscular dystrophy: assessed by multi-parameter cardiovascular magnetic resonance. (2023/12/11) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Evaluation of Chemically Modified Nucleic Acid Analogues for Splice Switching Application. (2023/12/11) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Safety concerns surrounding AAV and CRISPR therapies in neuromuscular treatment. (2023/12/08) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne's Muscular Dystrophy. (2023/12/07) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne's Muscular Dystrophy. (2023/12/07) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne's Muscular Dystrophy. Reply. (2023/12/07) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Networking to Optimize Dmd exon 53 Skipping in the Brain of mdx52 Mouse Model. (2023/12/07) ♡
• Mutational spectrum and phenotypic variability of Duchenne muscular dystrophy and related disorders in a Bangladeshi population. (2023/12/06) ♡
• Replenishing NAD(+) content reduces aspects of striated muscle disease in a dog model of Duchenne muscular dystrophy. (2023/12/04) ♡
• Development of Conformationally Restricted Negamycin Derivatives for Potent Readthrough Activity. (2023/12/04) ♡
• A fat- and sucrose-enriched diet causes metabolic alterations in mdx mice. (2023/12/01) ♡
• Appendicular lean mass index changes in patients with Duchenne muscular dystrophy and Becker muscular dystrophy. (2023/12/01) ♡
• Ryanodine receptor type 1 content decrease-induced endoplasmic reticulum stress is a hallmark of myopathies. (2023/12/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Impact of the Inhibition of Organic Anion Transporter on Tricyclo-DNA-Mediated Exon Skipping in the mdx Mouse Model. (2023/12/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Challenges of Assessing Exon 53 Skipping of the Human DMD Transcript with Locked Nucleic Acid-Modified Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy. (2023/12/01) ♡
• Prenatal diagnosis of 1408 foetuses at risk of DMD/BMD by MLPA and Sanger sequencing combined with STR linkage analysis. (2023/12/01) ♡
• Longitudinal assessment of skeletal muscle functional mechanics in the DE50-MD dog model of Duchenne muscular dystrophy. (2023/12/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.